Recurrence of Arrhythmias After Pulmonary Veins Isolation Detected by ICM

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00789139

Acronym

RAPID XT

Enrollment

Registered

2008-11-11

Start date

2008-10-31

Completion date

2013-07-31

Last updated

2015-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

Post Marketing study, Interventional, Prospective, non randomised Describe how the MD is using the information of the ICM in addition of standard FU(clinical exam and holter 24h)post AF ablation(1 year FU).

Interventions

DEVICEICM Implantation

Sub cutaneous implantation of the ICM

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* AF thermoablation indication * Informed Consent signed, * Age between 18 & 75

Exclusion criteria

* Participation to other clinical trial * Non compliant patient * Pregnant women * Left Atrial thrombus * Endocarditis, infection

Design outcomes

Primary

Measure	Time frame
Clinical exam and ECG record	one month, 3 months, 6 months , 12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026